NCT05557734

Brief Summary

Anal fistula is an abnormal tract communicating an external opening in the perianal skin with an internal opening in the anal canal. Anal fistula is treated by fistulotomy . sphincter sparing procedures are usually done under general anesthesia omitting neuromuscular blocking agents in order to preserve sphincter tone intraoperatively. The aim of this study is to evaluate the effect of caudal block analgesia versus perianal block analgesia combined with general anesthesia on the postoperative analgesic profile and the tone of external anal sphincter in sphincter sparing surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 28, 2022

Completed
1 year until next milestone

Study Start

First participant enrolled

October 14, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

December 21, 2023

Status Verified

December 1, 2023

Enrollment Period

3 months

First QC Date

September 24, 2022

Last Update Submit

December 17, 2023

Conditions

Keywords

caudalperianal blockanal sphincter sparing procedurespostoperative pain

Outcome Measures

Primary Outcomes (1)

  • time to first analgesic request after the recovery of the patient.

    duration of postoperative analgesia

    24 hours

Secondary Outcomes (4)

  • postoperative pain intensity

    24 hours

  • Assessment of External anal sphincter muscle tone intraoperative

    2 hours

  • Total post operative opioid consumption

    24 hours

  • incidence of complications

    24 hours

Study Arms (2)

caudal epidural group

ACTIVE COMPARATOR

the patient will be positioned in lateral position, sterilized from the iliac crest margin to the lower buttock by betadine and will be covered by sterile drapes exposing the sacral area. Sacral horns will be palpated and sacral hiatus and epidural area will be determined at S4-S5 level through the ultrasound. Short axis (transverse) will be used first to identify the two sacral cornua as two hyperechoic reverse U-shaped structure "Frog sign" and the sacrococcygeal ligament in between and epidural space beneath. An 18-gauge epidural needle (length 90 mm) will be used for direct puncture of sacrococcygeal membrane out of plane then the probe will be rotated to long axis (longitudinal) and the needle will be seen in plane in the epidural space. Injection of 40 ml 0.125% bupivacaine will expand the epidural space. The patient will be repositioned to lithotomy position and surgery will start after 5 min. of preparing the patient and sterilization to the surgery

Procedure: caudal block

perianal block group

ACTIVE COMPARATOR

, the patient will be in the lithotomy position, paint and drape the area of the block under strict aseptic precaution, draw a circle with a radius of 2.5cm around anal opening, mark a point at 2,4,8,10 clock position, prepare 40 ml 0.125% bupivacaine, use 1.5-inch 23/24 gauge needle connected to 10 ml syringe, insert full length of the needle into the ischiorectal fat immediately peripheral to the external sphinchter. This injection scheme target the terminal nerve branches of the anus rather than blocking the trunk of major nerves. At 2 clock position, inject 2-3 ml of LA with tilting in lateral direction,withdraw needle 1cm and after every 1cm inject 2-3ml of LA, repeat procedure at 4,8,10 clock position, remaining around 10 ml of LA is used to infiltrate in subcutaneous tissue in circumference of anal opening.

Procedure: perianal block

Interventions

caudal blockPROCEDURE

injection of local anesthestic through the scral hiatus into the sacral canal to reach caudal epidural space

Also known as: caudal epidural block
caudal epidural group

local anesthestic infiltration in the perianal area to block terminal branches of the nerves supplying the anal canal

perianal block group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old patients
  • ASA I-IIIpatients
  • Patients with complex anal fistula

You may not qualify if:

  • known hypersensitivity to amide type local anesthetics
  • Patients with contraindications to caudal block or perianal block: use of anticoagulant medication, local infection in the intervention site, increased intracranial pressure and severe aortic and / or mitral valve stenosis.
  • Patients who do not accept regional anesthesia
  • BMI (Body mass index) \> 35 kg/m2
  • Anatomical abnormalities and previous surgeries involving the sacrum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo university hospitals

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeMotor Activity

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsBehavior

Study Officials

  • Osama M Assad, professor

    Anesthesia department , cairo university

    PRINCIPAL INVESTIGATOR
  • Amany H Saleh, assprofessor

    Anesthesia department , Cairo university

    STUDY DIRECTOR
  • Mona H Elsherbiny, lecturer

    Anesthesia department , cairo university

    STUDY CHAIR

Central Study Contacts

Abdelmoneim A Abdelmoneim, lecturer

CONTACT

Marina B Helmy, resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Double blinded(the surgeon and the outcome assessor)
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

September 24, 2022

First Posted

September 28, 2022

Study Start

October 14, 2023

Primary Completion

January 1, 2024

Study Completion

February 1, 2024

Last Updated

December 21, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations